¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"reductase test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • nerve excitability test
    ½Å°æÀڱذ˻ç
  • neutralization test
    ÁßÈ­°Ë»ç
  • night penile tumescence test
    ¼ö¸éÀ½°æÆØÃ¢°Ë»ç
  • nonparametric test
    ºñÁöÇ¥°ËÁ¤
  • objective hearing test
    Ÿ°¢Ã»·Â°Ë»ç, °´°üÀûû·Â°Ë»ç
  • occlusion test
    ¸Â¹°¸²°Ë»ç, ±³ÇÕ°Ë»ç
  • occult blood test
    ÀáÇ÷°Ë»ç
  • one-tail test
    ´ÜÃø°ËÁ¤
  • opsonocytophagic test
    Ç×ü¸Å°³Å½½Ä´É°Ë»ç
  • oral glucose tolerance test
    °æ±¸Æ÷µµ´çºÎÇϰ˻ç
  • osmotic fragility test
    »ïÅõ¾ÐÃë¾à¼º°Ë»ç, »ïÅõ¾Ð¿©¸²¼º°Ë»ç
  • oxytocin challenge test
    ¿Á½ÃÅä½ÅºÎÇϰ˻ç
  • oxytocin sensitivity test
    ¿Á½ÃÅä½Å¹Î°¨µµ°Ë»ç
  • test object
    ½ÃÇè´ë»ó, Ç¥½Ä¹°
  • parametric test
    ÁöÇ¥°ËÁ¤
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • alternate binaural loudness balance test
    ¾çÀ̱³´ë(¼º) À½ÆòÇü°Ë»ç
  • alternate cover test
    ±³´ë°¡¸²°Ë»ç
  • alternate prism cover test
    ±³´ëÇÁ¸®Áò°¡¸²°Ë»ç
  • ames test
    ¿¡ÀÓ½º°Ë»ç(¡­ËþÞÛ)
  • aminopyrine breath test
    ¾Æ¹Ì³ëÇǸ°È£Èí°Ë»ç
  • anesthetic test of pulp
    Ä¡¼ö¸¶Ãë°Ë»ç.
  • antibody absorption test
    Ç×üÈí¼ö½ÃÇè(ù÷ô÷ýåâ¥ãËúÐ).
  • antibody identification test
    Ç×üȮÀΰ˻ç
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • anticomplement immunofluorescent test
    Ç׺¸Ã¼¸é¿ªÇü±¤½ÃÇè.
  • antiformin test
    ¾ÈƼÆ÷¸£¹Î½ÃÇè.
  • antiglobulin test
    Çױ۷κҸ°½ÃÇè.
  • antiglobulin test
    Çױ۷κҸ°½ÃÇè
  • antiglobulin test, direct
    Á÷Á¢ Çױ۷κи° °Ë»ç
  • antiglobulin test, indirect
    °£Á¢Çױ۷κҸ° °Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • constriction test
    ¾Ð¹Ú½ÃÇè(äâÚÞãËúÐ).
  • consumption test
    ¼Ò¸ð¿©ºÎ½ÃÇè
  • contraction stress test
    ¼öÃà ÀÚ±Ø °Ë»ç
  • contraction test
    ¼öÃà °Ë»ç
  • control test
    ´ëÁ¶½ÃÇè(ÊÙËàÌ´).
  • conversational voice test
    ȸȭÀ½°Ë»ç
  • coombs antiglobulin test
    Å©¿òÁîÇױ۷κó½ÃÇè(¡­ãËúÐ)
  • coombs test
    Å©¿òÁî °Ë»ç(ËþÞÛ)
  • coordination test
    ¼öÁ·ÇùÁ¶±â´É°Ë»ç(â¢ðëúððàѦÒöËþÞÛ).
  • copper reduction test
    ±¸¸®È¯¿ø½ÃÇè
  • copper sulfate test
    Ȳ»êµ¿°Ë»ç
  • cortisone glucose tolerance test =CGTT
    ÄÚ¸£Æ¼¼Õ Æ÷µµ´ç ºÎÇϽÃÇè(¡­øã Ô¬ÓØÝ¶ùÃãËúÐ).
  • cover test
    Â÷Æó½ÃÇè.
  • cover test
    °¡¸²°Ë»ç
  • cover-uncover test
    °¡¸²-¾È°¡¸²°Ë»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
IFA test Indirect Fluorescent Antibody test
IHA test Indirect Hem-Agglutination test
MEM Test Macrophage Electrophoretic Mobility Test
MR test Methyl Red test
NBT test Nitro-Blue Tetrazolium (dye reduction) test
  ; Chronic Granulomatous DiseaseÁø´Ü¿¡ »ç¿ë...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
BNT Boston Naming Test
BHT Breath hydrogen test
BOTMP Bruininks Oseretsky Test of Motor Proficiency
BITE Bulimia Investigatory Test Edinburgh
T C)-test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Fishberg concentration test
    Çǽ¬¹ö±× ³óÃà ½ÃÇè
    200§¢ ÀÌÇÏÀÇ ¾×ü°¡ µé¾î°£ Àú³á ½Ä»ç¸¦ ÇǰËÀÚ¿¡°Ô ÁÖ°í, ÀÌÈÄ¿¡´Â ¾Æ¹« °Íµµ ÁÖÁö ¾Ê´Â´Ù. ¾ß°£¿¡ ¹è¼³µÈ ¿ä´Â ¹ö¸®°í À̸¥ ¾ÆÄ§ÀÇ ¿ä¸¦ ¸ð¾Æ³õ°í, ÇǰËÀÚ´Â ÀáÀ» Àڸ鼭 1½Ã°£ ÈÄ¿Í 2½Ã°£ ÈÄÀÇ ¿ä¸¦ äÃëÇÑ´Ù. ÀÌ 3°¡ÁöÀÇ ¿ä Ç¥º» Áß ¾î´À Çϳª¶óµµ ºñÁßÀÌ 1.024 ¹Ì¸¸ÀÌ¸é ½Å ±â´É ºÎÀüÀÌ´Ù.
  • fistula test
    ´©°ø °Ë»ç, ´©°ø ½ÃÇè
  • flicker fusion test
    ÇÁ¸¯Ä¿ À¶ÇÕ °Ë»ç
  • flocculation test
    ¸é»ó ¹ÝÀÀ ½ÃÇè, ¸é»ó ½ÃÇè
    ħ°­ ¹ÝÀÀÀÇ ÀÏÁ¾. °¡¿ë¼º Ç׿øÀÌ ±×°Í¿¡ ´ëÀÀÇϴ ħ°­¼Ò¿Í ¹ÝÀÀÇÏ¿© ħ°­¹°À» Çü¼ºÇÏ´Â °æ¿ì ±×¶§¿¡ »ý±ä ħÀüÀÌ ¸é»óÀ¸·Î º¸ÀÌ´Â °æ¿ì¸¦ ƯÈ÷ ¸é»ó ¹ÝÀÀÀ̶ó°í Çϴµ¥ ħ°­ ¹ÝÀÀ°ú º»ÁúÀûÀ¸·Î ´Ù¸¥ °ÍÀº ¾Æ´Ï°í ÁÖ·Î Ç׿ø ÀÔÀÚÀÇ Å©±â¿Í °ü°è°¡ ÀÖ´Ù. ´ëÇ¥ÀûÀÎ °ÍÀ¸·Î¼­ ¸»ÀÇ Ç×ü¸¦ »ç¿ëÇßÀ» ¶§ÀÇ µ¶¼Ò-Ç×µ¶¼Ò ¹ÝÀÀÀÎ °æ¿ìÀÇ Ç×ü °úÀ׿ª¿¡¼­ ÀüÇüÀûÀÎ ÀÌ ¹ÝÀÀÀ» º¼ ¼ö ÀÖ´Ù.
  • fluorescent antinuclear antibody test
    Çü±¤ Ç×ÇÙ Ç×ü ½ÃÇè
  • fluorescent treponemal antibody test
    ¸Åµ¶ Æ®·¹Æ÷³×¸¶ Çü±¤ Ç×ü °Ë»ç, Çü±¤¼º ¸Åµ¶±Õ Ç×ü ½ÃÇè¹ý
  • foraminal compression test
    Ãß°£°ø ¾Ð¹Ú °Ë»ç
    .
  • formaldehyde test
    Æ÷¸§¾Ëµ¥ÇÏÀÌµå ½ÃÇè
  • Fournier test
    Ǫ¸£´Ï¿¡ ½ÃÇè
  • fragility test
    Ãë¾à ½ÃÇè
    ÀûÇ÷±¸ ÆÄ±« ½ÃÇè.
  • Freda test
    ÇÁ·¹´Ù ½ÃÇè
  • Frei's test
    ÇÁ¶óÀÌ ½ÃÇè
  • fructose test
    °ú´ç ½ÃÇè
  • Frye test
    ÇÁ¶óÀÌ ½ÃÇè
  • function test
    ±â´É ½ÃÇè
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
16-dehydroprogesterone reductase <enzyme> Reduces 16-dehydroprogesterone to 17-isoprogesterone; neither NADH or NADPH with or without flavin nucleotides are used as electron donors
Registry number: EC 1.3.99.-
Synonym: 16-dhpr
(26 Jun 1999)
1-cyclohexenylcarbonyl-CoA reductase <enzyme> An enoyl coenzyme a reductase from streptomyces collinus; catalyses the conversion of 1-cyclohexenylcarbonyl coenzyme a to cyclohexylcarbonyl-CoA; possibly catalyses the final reductive step in the conversion of shikimic acid into ansatrienin a
Registry number: EC 1.3.1.-
Synonym: 1-chc-CoA reductase
(26 Jun 1999)
1-nitropyrene reductase <enzyme> Nadh or NADPH can serve as reducing agent to form 1-aminopyrene
Registry number: EC 1.7.-
Synonym: 1-nitropyrene nitroreductase
(26 Jun 1999)
2,5-diamino-6-hydroxy-4-ribosylaminopyrimidine-5'-phosphate reductase <enzyme> Nadp-dependent; forms 2,5-diamino-6-hydroxy-4-ribitylaminopyrimidine-5'-phosphate; intermediate in riboflavin biosynthesis
Registry number: EC 1.1.1.-
Synonym: dahrampp reductase, 2,5-diamino-4-oxy-6-ribosylaminopyrimidine-5'-phosphate reductase
(26 Jun 1999)
2,5-diketo-D-gluconate 5-reductase <enzyme> Catalyses reversibly the stereospecific NADPH-dependent reduction of 2,5-diketo-d-gluconate to 2-keto-l-gluconate
Registry number: EC 1.1.1.-
Synonym: 2,5-dkg reductase
(26 Jun 1999)
2-aminobenzoyl-CoA monooxygenase-reductase <enzyme> Flavoenzyme; contains fad; mechanism not known
Registry number: EC 1.14.99.-
Synonym: ab-CoA monooxygenase-reductase, 2-aminobenzoyl-coenzyme a monooxygenase-reductase
(26 Jun 1999)
2-enoate reductase <enzyme> Am iron-sulfur flavoprotein which reduces alpha,beta-unsaturated carboxylate anions in a NADPH-dependent reaction to saturated carboxylated anions
Registry number: EC 1.3.1.31
(26 Jun 1999)
2-enoyl-CoA reductase Acyl-CoA dehydrogenase (NADP+).
(05 Mar 2000)
2-hydroxy-3-oxopropionate reductase <enzyme> Catalyses reversibly the reduction of glycerate to 2-hydroxy-3-oxopropanate in the presence of nad(p+)
Registry number: EC 1.1.1.60
Synonym: tartronate saemialdehyde reductase, tsa reductase
(26 Jun 1999)
2'-hydroxyisoflavone reductase <enzyme> An isoflavone reductase that catalyses the oxidation of vestitone to 2'-hydroxyformononetin in the presence of nadp+; also reduces a 2'-hydroxyisoflavone to an isoflavonone; from chick pea and alfalfa; amino acid sequence given in first source
Registry number: EC 1.3.1.45
Synonym: NADPH-isoflavone oxidoreductase, vestitone-nadp+ oxidoreductase, isoflavone reductase, vestitone reductase
(26 Jun 1999)
2-methylacetoacetyl-CoA reductase <enzyme> From ascaris lumbricoides muscle; acts on 2-methylacetoacetyl-CoA, 3-keto-2-methyl pentanoyl-CoA and on their ethyl esters in place of CoA
Registry number: EC 1.1.1.-
Synonym: 2-methylacetoacetyl-coenzyme a reductase
(26 Jun 1999)
2-methyl branched-chain enoyl-CoA reductase <enzyme> Important in the reversal of beta-oxidation under anaerobic conditions in ascaris suum
Registry number: EC 1.3.1.52
Synonym: 2-methyl bce-CoA reductase
(26 Jun 1999)
2-oxocarboxylate reductase <enzyme> From various clostridia; acts on phenylpyruvate and 2-oxo-h-methylpentanoate
Registry number: EC 1.1.1.-
(26 Jun 1999)
3-dehydroecdysone 3alpha-reductase <enzyme> Uses NADPH, converts 3-dehydroecdysone to 3-epiecdysone
Registry number: EC 1.1.1.-
Synonym: 3de 3alpha-reductase
(26 Jun 1999)
3-dehydroecdysone 3beta-reductase <enzyme> Converts 3-dehydroecdysone into ecdysone; a 36 kD enzyme from haemolymph of cotton leafworm spodoptera littoralis, involved in ecdysteroid biosynthesis
Registry number: EC 1.1.3.-
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
ÅëÇÕ°Ë»ö ¿Ï·á